Romero Carlos A MD - Mineola, New York 11501

Romero Carlos A MD is categorized under Doctors in Mineola, NY .

Business Name: Romero Carlos A MD
Contact Person: Carlos Romero
Address: 173 Mineola Boulevard # 401, Mineola, New York 11501
Phone Number: (516) 741-6464
Website Address: winthrop.org
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Goldman Jason D MD - Mineola, NY 11501
Rosenfeld Warren N MD - Mineola, NY 11501
Taylor Sharon I MD - Mineola, NY 11501
Steinberg Paul Steven MD - Mineola, NY 11501
Yuan Lily L MD - Mineola, NY 11501
Yu Namyi MD - Mineola, NY 11501
Weston Shiobhan R MD - Mineola, NY 11501
Molho Laura MD - Mineola, NY 11501
Levine Gary M MD - Mineola, NY 11501
Korrapati Madhu MD - Mineola, NY 11501
Avila Vincent S MD - Mineola, NY 11501
Meneshian Alex V MD - Mineola, NY 11501
Zuckerman David M MD - Mineola, NY 11501
Immanuel Gamaliel MD - Mineola, NY 11501
Persaud Lisa N MD - Mineola, NY 11501
Aquino Marcella MD - Mineola, NY 11501
Glanz Sidney MD - Mineola, NY 11501
Yu Song MD - Mineola, NY 11501
Cain Kristen MD - Mineola, NY 11501
Bonasera Robert J MD - Mineola, NY 11501

The company Romero Carlos A MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Romero Carlos A MD, and the business now earns $500.000 to $999.999 per annum.

Romero Carlos A MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Romero Carlos A MD, please call Carlos Romero with the phone number (516) 741-6464 or visit its single location at 173 Mineola Boulevard # 401 in Mineola, New York 11501.

The location of the single location can also be found using the coordinates 40.74438,-73.64172. Read more details about this business on the webpage winthrop.org or follow the company’s social media accounts, on Twitter and on Facebook.